CSIMarket
 
Niagen Bioscience Inc   (NASDAQ: NAGE)
 

Niagen Bioscience Inc's Customers Performance

NAGE



 
NAGE's Source of Revenues During the corresponding time, Niagen Bioscience Inc saw a revenue deteriorated by -4.28 % year on year, sequentially revenue fell by -5.37 %. While revenue at the Niagen Bioscience Inc 's corporate clients

List of NAGE Customers




for the same period Niagen Bioscience Inc revnue deteriorated by -4.28 % year on year, sequentially revenue fell by -5.37 %.

List of NAGE Customers

Niagen Bioscience Inc's Business Units
Corporate and other    0.24 % of total Revenue
Consumer Products segment    71.21 % of total Revenue
Ingredients segment    27.21 % of total Revenue
Analytical Reference Standards and Services segment    1.34 % of total Revenue
Subtotal Niagen Related    97.13 % of total Revenue
Tru Niagen Consumer Product    71.21 % of total Revenue
Food-grade Niagen    23.22 % of total Revenue
Pharmaceutical-grade Niagen    2.7 % of total Revenue
Subtotal Other Goods and Services    2.87 % of total Revenue
Other Ingredients    1.29 % of total Revenue
Reference Standards    1.31 % of total Revenue
Consulting and Other    0.27 % of total Revenue
Consumer Products Subtotal Niagen Related    71.21 % of total Revenue
Consumer Products Tru Niagen Consumer Product    71.21 % of total Revenue
Ingredients Subtotal Niagen Related    25.92 % of total Revenue
Ingredients Food-grade Niagen    23.22 % of total Revenue
Ingredients Pharmaceutical-grade Niagen    2.7 % of total Revenue
Ingredients Subtotal Other Goods and Services    1.29 % of total Revenue
Ingredients Other Ingredients    1.29 % of total Revenue
Analytical Reference Standards and Services Subtotal Other Goods and Services    1.34 % of total Revenue
Analytical Reference Standards and Services Reference Standards    1.31 % of total Revenue
Analytical Reference Standards and Services Consulting and Other    0.04 % of total Revenue
Corporate and other Subtotal Other Goods and Services    0.24 % of total Revenue
Corporate and other Consulting and Other    0.24 % of total Revenue






Niagen Bioscience Inc's Comment on Sales, Marketing and Customers



The company operates globally, serving customers in the dietary supplement, food and beverage, cosmetic, pharmaceutical, and life sciences industries. Its product offerings include small quantities of highly characterized phytochemicals, natural products, and plant-based materials used to ensure the quality of raw materials and finished products. The company also provides research services for natural product research and development. The pharmaceutical segment focuses on developing NAD+ precursors for therapeutic applications in advanced aging rare diseases, though it currently does not generate revenue. The addressable market includes the global wellness industry, personal care and beauty, healthy eating, nutrition and weight loss, traditional and complementary medicine, the spa market, the global dietary supplements market, and the intravenous hydration therapy market. No single customer accounted for more than 10% of net sales. Net sales increased from approximately $99.6 million in 2024 to $129.4 million in 2025. The company's segments included Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the latter segment sold in 2026.





Niagen Bioscience Inc’s Comment on Sales, Marketing and Customers


The company operates globally, serving customers in the dietary supplement, food and beverage, cosmetic, pharmaceutical, and life sciences industries. Its product offerings include small quantities of highly characterized phytochemicals, natural products, and plant-based materials used to ensure the quality of raw materials and finished products. The company also provides research services for natural product research and development. The pharmaceutical segment focuses on developing NAD+ precursors for therapeutic applications in advanced aging rare diseases, though it currently does not generate revenue. The addressable market includes the global wellness industry, personal care and beauty, healthy eating, nutrition and weight loss, traditional and complementary medicine, the spa market, the global dietary supplements market, and the intravenous hydration therapy market. No single customer accounted for more than 10% of net sales. Net sales increased from approximately $99.6 million in 2024 to $129.4 million in 2025. The company's segments included Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the latter segment sold in 2026.








NAGE's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Niagen Bioscience Inc 247.51 129.08 15.99 117
SUBTOTAL 0.00 0.00 0.00 -

Sources: Niagen Bioscience Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Niagen Bioscience Inc’s corporate clients.
For your research, we’ve provided 9 tables on Niagen Bioscience Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.